Questions raised about the use of 'ALS mice' are prompting a broad reappraisal of the way that drugs are tested in animal models of neurodegenerative disease. Jim Schnabel reports.
This is a preview of subscription content, log in via an institution to check access.
References
Benatar, M. Neurobiol. Dis. 26, 1–13 (2007).
Gordon, P. H. et al. Lancet Neurol. 6, 1045–1053 (2007).
Scott, S. et al. Amyotroph. Lateral Scler. 9, 4–15 (2008).
Zhu, S. et al. Nature 417, 74–78 (2002).
Drachman, D. B. et al. Ann. Neurol. 52, 771–778 (2002).
Neumann, M. et al. Science 314, 130–133 (2006).
Yang, S.-H. et al. Nature 453, 921–924 (2008).
Additional information
Jim Schnabel is a freelance writer based in Maryland.
Related links
Related links
Related links in Nature Research
Related external links
Rights and permissions
About this article
Cite this article
Schnabel, J. Neuroscience: Standard model. Nature 454, 682–685 (2008). https://doi.org/10.1038/454682a
Published:
Issue Date:
DOI: https://doi.org/10.1038/454682a
- Springer Nature Limited
This article is cited by
-
Effects of astrocyte on neuronal outgrowth in a layered 3D structure
BioMedical Engineering OnLine (2019)
-
Changes in renal medulla gene expression in a pre-clinical model of post cardiopulmonary bypass acute kidney injury
BMC Genomics (2014)
-
Mapping ecologically relevant social behaviours by gene knockout in wild mice
Nature Communications (2014)
-
A Review of the Institute of Medicine’s Analysis of using Chimpanzees in Biomedical Research
Science and Engineering Ethics (2014)
-
Identification of Rat Respiratory Mucosa Stem Cells and Comparison of the Early Neural Differentiation Potential with the Bone Marrow Mesenchymal Stem Cells In Vitro
Cellular and Molecular Neurobiology (2014)